EMA Marketing Authorization of New Drugs in January 2026
Shots: Company: BioNet Product: VacPertagen Active Ingredient: Pertussis Vaccine (Recombinant, Acellular, Component,…
Read article →
Next Pharma Summit 2026 | May 19-20, Dubrovnik
Next Pharma Summit is a 2-day, multi-stage conference for pharma professionals passionate about Digital, Commercial,…
Read article →
Teva and Sanofi Report P-IIb (RELIEVE UCCD) LTE Study Data on Duvakitug in Inflammatory Bowel Disease
Shots: Ref: Teva | Image: Teva & Sanofi | Press Release Related News: Sanofi Reports P-III (LEAP2MONO) Trial Data on…
Read article →
CStone Receives the US FDA IND Clearance to Initiate P-II Trial of CS2009 in Advanced Solid Tumors
Shots: Ref: PRnewswire | Image: CStone | Press Release Related News: CStone Pharmaceuticals’ Cejemly Receives the CHMP’s…
Read article →
GSK Reports the EC Approval of Exdensur (Depemokimab) for Asthma with Type 2 Inflammation and CRSwNP
Shots: Ref: GSK | Image: GSK | Press Release Related News: NMPA Accepts GSK’s Arexvy Submission to Prevent Lower…
Read article →
Bio-Techne’s Ella Platform Receives the CE-IVD Marking for Rapid, Cartridge‑Based Immunoassays
Shots: Ref: PRnewswire | Image: Bio-Techne | Press Release Related News: Novocure Receives the US FDA Approval of Optune…
Read article →
VB Spine to Acquire Exclusive Rights to xvision Spine System from Augmedics
Shots: Ref: Businesswire | Image: VB Spine & Augmedics | Press Release Related News: LEX Diagnostics Receives 510(k)…
Read article →
Eli Lilly Reports P-III (LIBRETTO-432) Trial Findings on Retevmo (Selpercatinib) in RET Fusion-Positive NSCLC
Shots: Ref: Eli Lilly | Image: Eli Lilly | Press Release Related News: Eli Lilly Reports P-IIIb (TOGETHER-PsA) Trial…
Read article →